Works matching IS 13524585 AND DT 2023 AND VI 29 AND IP 6

Results: 17

Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 671, doi. 10.1177/13524585231164296

By:

Palladino, Raffaele;
Marrie, Ruth Ann;
Majeed, Azeem;
Chataway, Jeremy

Publication type:

Article

A spoonful of sugar: The risks of negative health outcomes of polypharmacy in MS is a bitter reality.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 765, doi. 10.1177/13524585231154251

By:

Roman, Sharon

Publication type:

Article

Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 741, doi. 10.1177/13524585231162586

By:

Kolind, Shannon;
Gaetano, Laura;
Assemlal, Haz-Edine;
Bernasconi, Corrado;
Bonati, Ulrike;
Elliott, Colm;
Hagenbuch, Niels;
Magon, Stefano;
Arnold, Douglas L;
Traboulsee, Anthony

Publication type:

Article

Seizure risk in multiple sclerosis patients treated with disease-modifying therapy: A systematic review and network meta-analysis.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 657, doi. 10.1177/13524585231151400

By:

Dang, Yew Li;
Yong, Vivien TY;
Sharmin, Sifat;
Perucca, Piero;
Kalincik, Tomas

Publication type:

Article

Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 731, doi. 10.1177/13524585231161492

By:

Fink, Katharina;
Gorczyca, Agnes;
Alping, Peter;
Englund, Simon;
Farmand, Susan;
Langer-Gould, Annette M;
Piehl, Fredrik;
McKay, Kyla;
Frisell, Thomas;
Razaz, Neda

Publication type:

Article

The contribution of neurofilament light chain to better characterize pediatric multiple sclerosis (editorial on: Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial)

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 668, doi. 10.1177/13524585231161148

By:

Ghezzi, Angelo;
Neuteboom, Rinze F

Publication type:

Article

Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 680, doi. 10.1177/13524585231162262

By:

Elliott, Colm;
Rudko, David A;
Arnold, Douglas L;
Fetco, Dumitru;
Elkady, Ahmed M;
Araujo, David;
Zhu, Bing;
Gafson, Arie;
Tian, Zhe;
Belachew, Shibeshih;
Bradley, Daniel P;
Fisher, Elizabeth

Publication type:

Article

Imposter clinical trials or answering questions with observational data.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 645, doi. 10.1177/13524585231162261

By:

Cutter, Gary

Publication type:

Article

Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 719, doi. 10.1177/13524585231161494

By:

Giovannoni, Gavin;
Boyko, Alexey;
Correale, Jorge;
Edan, Gilles;
Freedman, Mark S;
Montalban, Xavier;
Rammohan, Kottil;
Stefoski, Dusan;
Yamout, Bassem;
Leist, Thomas;
Aydemir, Aida;
Borsi, Laszlo;
Verdun di Cantogno, Elisabetta

Publication type:

Article

Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 748, doi. 10.1177/13524585221150743

By:

Chia, Nicholas H;
Redenbaugh, Vyanka;
Chen, John J;
Pittock, Sean J;
Flanagan, Eoin P

Publication type:

Article

Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 757, doi. 10.1177/13524585221151124

By:

Schwake, Carolin;
Pakeerathan, Thivya;
Kleiter, Ingo;
Ringelstein, Marius;
Aktas, Orhan;
Korporal-Kuhnke, Mirjam;
Wildemann, Brigitte;
Jarius, Sven;
Bayas, Antonios;
Pul, Refik;
Ceylan, Ulas;
Faissner, Simon;
Hellwig, Kerstin;
Ayroza Galvao Ribeiro Gomes, Ana Beatriz;
Lipps, Philipp;
Pröbstel, Anne-Katrin;
Kümpfel, Tania;
Oswald, Eva;
Then Bergh, Florian;
Gödel, Clemens

Publication type:

Article

Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC).

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 753, doi. 10.1177/13524585221140271

By:

Jakimovski, Dejan;
Kavak, Katelyn S;
Zakalik, Karen;
Coetzee, Timothy;
Gottesman, Malcolm;
Coyle, Patricia K;
Zivadinov, Robert;
Weinstock-Guttman, Bianca

Publication type:

Article

Selective vulnerability of brainstem and cervical spinal cord regions in people with non-progressive multiple sclerosis of Black or African American and European ancestry.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 691, doi. 10.1177/13524585221139575

By:

Okuda, Darin T;
Stanley, Thomas;
McCreary, Morgan;
Smith, Alexander;
Wilson, Andrew;
Pinho, Marco C;
Yu, Fang F;
Billiet, Thibo;
Van Hecke, Wim;
Ribbens, Annemie;
Zeydan, Burcu;
Kantarci, Orhun;
Guo, Xiaohu;
Moog, Tatum M

Publication type:

Article

Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 702, doi. 10.1177/13524585221139152

By:

Tsagkas, Charidimos;
Huck-Horvath, Antal;
Cagol, Alessandro;
Haas, Tanja;
Barakovic, Muhamed;
Amann, Michael;
Ruberte, Esther;
Melie-Garcia, Lester;
Weigel, Matthias;
Pezold, Simon;
Schlaeger, Regina;
Kuhle, Jens;
Sprenger, Till;
Kappos, Ludwig;
Bieri, Oliver;
Cattin, Philippe;
Granziera, Cristina;
Parmar, Katrin

Publication type:

Article

T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 648, doi. 10.1177/13524585221134216

By:

Reder, Anthony T;
Stuve, Olaf;
Tankou, Stephanie K;
Leist, Thomas P

Publication type:

Article

Olfactory threshold as a biomarker of disease activity.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 762, doi. 10.1177/13524585221122239

By:

Santos, Mónica;
Geraldes, Ruth;
Palace, Jacqueline

Publication type:

Article

Reply to letter to the editor: Olfactory threshold as a biomarker of disease activity.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 763, doi. 10.1177/13524585221122176

By:

Bsteh, Gabriel;
Berger, Thomas

Publication type:

Article